Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Chemical composition, immunostimulatory, cytotoxic and antiparasitic activities of the essential oil from Brazilian red propolis.

Sena-Lopes Â, Bezerra FSB, das Neves RN, de Pinho RB, Silva MTO, Savegnago L, Collares T, Seixas F, Begnini K, Henriques JAP, Ely MR, Rufatto LC, Moura S, Barcellos T, Padilha F, Dellagostin O, Borsuk S.

PLoS One. 2018 Feb 1;13(2):e0191797. doi: 10.1371/journal.pone.0191797. eCollection 2018.

2.

Recurrent Immune Thrombocytopenia After Influenza Vaccination: A Case Report.

Hamiel U, Kventsel I, Youngster I.

Pediatrics. 2016 Dec;138(6). pii: e20160124. Epub 2016 Nov 8.

3.

The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper.

Halsey NA, Talaat KR, Greenbaum A, Mensah E, Dudley MZ, Proveaux T, Salmon DA.

Vaccine. 2015 Dec 30;33 Suppl 5:F1-F67. doi: 10.1016/j.vaccine.2015.10.080. Review.

4.

Safety of measles-containing vaccines in 1-year-old children.

Klein NP, Lewis E, Fireman B, Hambidge SJ, Naleway A, Nelson JC, Belongia EA, Yih WK, Nordin JD, Hechter RC, Weintraub E, Baxter R.

Pediatrics. 2015 Feb;135(2):e321-9. doi: 10.1542/peds.2014-1822. Epub 2015 Jan 5.

5.

Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases.

Perricone C, Ceccarelli F, Nesher G, Borella E, Odeh Q, Conti F, Shoenfeld Y, Valesini G.

Immunol Res. 2014 Dec;60(2-3):226-35. doi: 10.1007/s12026-014-8597-x. Review.

PMID:
25427992
6.

Measles-mumps-rubella vaccination induced thrombocytopenia: a case report and review of the literature.

Owatanapanich S, Wanlapakorn N, Tangsiri R, Poovorawan Y.

Southeast Asian J Trop Med Public Health. 2014 Sep;45(5):1053-7. Review.

PMID:
25417506
7.

Vaccine administration and the development of immune thrombocytopenic purpura in children.

Cecinati V, Principi N, Brescia L, Giordano P, Esposito S.

Hum Vaccin Immunother. 2013 May;9(5):1158-62. doi: 10.4161/hv.23601. Epub 2013 Jan 16. Review.

8.

Drug-induced immune thrombocytopaenia: results from the Berlin Case-Control Surveillance Study.

Garbe E, Andersohn F, Bronder E, Salama A, Klimpel A, Thomae M, Schrezenmeier H, Hildebrandt M, Späth-Schwalbe E, Grüneisen A, Meyer O, Kurtal H.

Eur J Clin Pharmacol. 2012 May;68(5):821-32. doi: 10.1007/s00228-011-1184-3. Epub 2011 Dec 21.

PMID:
22187020
9.

Drug-induced immune thrombocytopenia: a descriptive survey in the French PharmacoVigilance database.

Moulis G, Sommet A, Sailler L, Lapeyre-Mestre M, Montastruc JL; French Association Of Regional Pharmacovigilance Centers.

Platelets. 2012;23(6):490-4. doi: 10.3109/09537104.2011.633179. Epub 2011 Nov 18.

PMID:
22098130
10.

Thrombocytopenic purpura after measles-mumps-rubella vaccination: a systematic review of the literature and guidance for management.

Mantadakis E, Farmaki E, Buchanan GR.

J Pediatr. 2010 Apr;156(4):623-8. doi: 10.1016/j.jpeds.2009.10.015. Epub 2010 Jan 25. Review.

PMID:
20097358
11.

Association between drug and vaccine use and acute immune thrombocytopenia in childhood: a case-control study in Italy.

Bertuola F, Morando C, Menniti-Ippolito F, Da Cas R, Capuano A, Perilongo G, Da Dalt L.

Drug Saf. 2010 Jan 1;33(1):65-72. doi: 10.2165/11530350-000000000-00000.

PMID:
20000868
12.

Measles vaccine adverse events reported in the mass vaccination campaign of Sichuan province, China from 2007 to 2008.

Shu M, Liu Q, Wang J, Ao R, Yang C, Fang G, Wan C, Guo W.

Vaccine. 2011 Apr 18;29(18):3507-10. doi: 10.1016/j.vaccine.2009.10.106. Epub 2009 Nov 10.

PMID:
19909830

Supplemental Content

Loading ...
Support Center